.

Macrogenics reported $-41808000 in EBIT for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Amgen AMGN:US $ 2176M 324M
AstraZeneca AZN:LN 181.11B 36.36B
Biogen BIIB:US $ 940.9M 409.4M
Bristol Myers Squibb BMY:US $ 3197M 9M
Cerulean Pharma CERU:US $ -8400450 1.14M
Daiichi Sankyo 4568:JP 34.38B 85.13B
Eli Lilly And LLY:US $ 1650.5M 919.4M
Epizyme EPZM:US $ -29806000 21.12M
Genmab GEN:DC 1.25B 733M
Geron GERN:US $ -27976000 699K
Gilead Sciences GILD:US $ 2029M 868M
Immunogen IMGN:US $ -61053000 38.2M
Johnson & Johnson JNJ:US $ 6941M 599M
Karyopharm Therapeutics KPTI:US $ -42908000 8.32M
Macrogenics MGNX:US $ -41808000 24.83M
Merk MRK:US $ 5711M 652M
Mirati Therapeutics MRTX:US $ -177205000 7.01M
Pfizer PFE:US $ 12099M 2104M
Puma Biotechnology PBYI:US $ 12.06M 12.8M
Regeneron Pharmaceuticals REGN:US $ 1306.9M 20.3M
Seattle Genetics SGEN:US $ -133111000 61K
Xencor XNCR:US $ -28000000 54.47M